June 12 (Reuters) - Bavarian Nordic A/S:
* REG-BAVARIAN NORDIC TO MANUFACTURE ADDITIONAL EBOLA VACCINES FOR JANSSEN
* BAVARIAN NORDIC TO MANUFACTURE ADDITIONAL EBOLA VACCINES FOR JANSSEN
* ENTERED NEW SUPPLY CONTRACT WITH JANSSEN VACCINES & PREVENTION VALUED AT USD 13.9 MLN
* MANUFACTURING OF VACCINES WILL BE INITIATED IN 2020, SUPPLY AND INVOICING WILL NOT OCCUR UNTIL 2021
* WILL MANUFACTURE, DELIVER BULK DRUG SUBSTANCE OF MVA-BN FILO VACCINE, WHICH JANSSEN HAS LICENSED AS PART OF EBOLA VACCINE REGIMEN Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.